At-Home Ketamine vs. IV Infusion Clinic: Cost, Safety, Results (2026)

The Two Modalities

In the United States right now, ketamine therapy is delivered in essentially two ways. The first is at-home sublingual: physician-prescribed troches or rapidly dissolving tablets taken at home during a structured session, with remote telehealth supervision. The second is the infusion clinic: intravenous or intramuscular ketamine administered in a medical facility under direct physician or nurse supervision. Both work. Neither is universally better. Which one is right for you depends on your medical complexity, your support system, your budget, and how much of your life you want to rebuild around getting to a clinic.

Safety: Where Each Setting Wins

The clinic model has real advantages that come from putting trained staff and emergency equipment in the same room as you. A nurse or physician is right there if your blood pressure spikes, you get nauseous, or you have a wave of acute anxiety, and any of those can be treated within seconds. Continuous monitoring runs for the whole session: automated BP cuff, pulse oximetry, sometimes cardiac monitoring. Defibrillator, airway tools, IV fluids, and rescue medications are on hand. For patients with significant medical complexity (cardiovascular disease, recent MI, uncontrolled hypertension), that level of in-the-room capability is the safer fit.

The at-home model wins on a different axis. Many patients have their best sessions at home precisely because they aren't in a medical setting; the familiarity of your own bedroom reduces baseline anxiety in a way that meaningfully changes the experience. Sublingual ketamine is also absorbed more slowly than IV, so the risk of an acute adverse reaction is proportionally lower. And legitimate at-home programs screen out high-risk patients before prescribing. That screening is itself a safety mechanism. The safest at-home program is one that says no to the wrong candidates, and a good intake process is your first safety net.

Efficacy: What the Data Shows

Real-world response rates between the two settings are roughly comparable. IV clinic-based protocols see 65 to 75 percent response in treatment-resistant depression. Sublingual at-home protocols see 60 to 70 percent in comparable populations. IV has higher bioavailability (approximately 100% versus 20–30% sublingual), but effective dosing compensates. Time to meaningful response is similar (24 to 72 hours for both), and the duration of effect between sessions is comparable (roughly one to two weeks).

The biggest efficacy variable in at-home treatment isn't the route of administration. It's set and setting: the psychological preparation you bring to each session. In the clinic, the setting is standardized and the staff guides you. At home, that responsibility falls more on you and your provider's protocols. We have a longer piece on this at the integration process.

Cost

For patients paying out of pocket, which is most of them, at-home runs roughly four to six times less expensive over a typical treatment course.

Convenience and Logistics

A clinic visit requires travel each way (often thirty to sixty minutes), two to three hours on-site, a driver for the trip home afterward, scheduling that fits the clinic's hours, and time off work. An at-home session requires a quiet, private 60-to-90-minute block, a trusted person available (not necessarily in the room), a four-hour fast beforehand, and no driving for the rest of the day.

For patients with full-time jobs, childcare responsibilities, chronic pain that makes travel difficult, or anyone in a rural area without a nearby clinic, the at-home option is often the only realistic one.

Who Should Choose Clinic

A clinic setting is the better fit if you have uncontrolled hypertension (above roughly 150/95), a recent cardiac event or significant cardiovascular disease, a history of severe adverse reactions to anesthesia, an active suicidal crisis that needs rapid and intensive intervention, no reliable support person at home, or very high body weight requiring higher doses that benefit from IV precision.

Who Should Choose At-Home

At-home is a good fit if you have a stable medical history (well-controlled hypertension is fine), a reliable support person available during sessions, a quiet and private space for treatment, geographic or financial barriers to clinic access, a preference for being in your own environment, and the willingness to do the prep work that makes home sessions work.

What the Decision Really Comes Down To

Most patients pursuing ketamine therapy aren't in a clinical emergency. They're dealing with chronic depression, anxiety, PTSD, or pain that has resisted other treatments. For that population, the relevant question isn't which setting is "safer" in the abstract; both are safe when done right. The relevant question is which setting they'll actually stick with for long enough to see results. A clinic course that gets abandoned after two sessions because the patient can't afford it or can't get the time off is less effective than a twelve-week at-home course they finish.

Frequently Asked Questions

Is at-home ketamine as effective as IV infusion clinics?

For most patients, yes. Real-world response rates are comparable — 60-70% in sublingual at-home programs vs. 65-75% in IV clinic protocols, both for treatment-resistant depression. IV has higher bioavailability (~100% vs. ~25-30% sublingual), but at-home dosing is adjusted upward to compensate. Time to response (24-72 hours) and duration of effect between sessions are similar. The biggest efficacy variable isn't the route — it's set, setting, and integration work.

How much cheaper is at-home ketamine than clinic IV?

Roughly 4-6× cheaper per treatment course. A standard 6-session IV induction at a clinic runs $2,400-$4,800 out-of-pocket. The same induction period at an at-home program like Discreet Ketamine runs $300-$500 (clinical care + medication). Ongoing maintenance follows the same ratio — clinic visits at $400-$800 each vs. at-home monthly plans starting at $250.

When should you choose IV ketamine over at-home?

Clinic-based IV is the better fit for: uncontrolled hypertension (above ~150/95), recent cardiac events or significant cardiovascular disease, history of severe adverse reactions to anesthesia, an active suicidal crisis needing rapid intensive intervention, no reliable support person at home, or very high body weight requiring IV-precision dosing. For maintenance treatment in stable patients, at-home is generally the better fit.

Is IV ketamine safer than at-home sublingual?

In specific senses, yes — a clinic has trained staff, continuous monitoring (BP cuff, pulse oximetry), and emergency equipment in the same room. But at-home programs build safety in differently: rigorous intake screening that excludes high-risk candidates, slower sublingual absorption (lower acute reaction risk), and remote physician availability. For appropriately screened patients, both settings are safe; the comparison is about what failure modes each setting handles best.

Does insurance cover IV ketamine for depression?

Almost never. IV ketamine is prescribed off-label for psychiatric conditions, and insurers don't cover off-label compounded ketamine. Spravato (intranasal esketamine) is the one ketamine modality with FDA approval and a realistic path to insurance coverage — though even that requires prior authorization and copays often run $150-$300/session. Most patients pay out-of-pocket for both clinic IV and at-home sublingual.

What's the time commitment difference?

A clinic visit is 30-60 minutes of travel each way, 2-3 hours on-site (prep, infusion, recovery), often a driver for the trip home, scheduling within clinic hours, and time off work. An at-home session is a 60-90 minute private block, a 4-hour pre-session fast, no driving for the rest of the day, and a peer supervisor reachable nearby. For full-time workers and parents, the at-home logistics are typically the only realistic option.

Can you switch from IV ketamine to at-home sublingual?

Yes — it's a common pathway. Patients who begin with IV for acute stabilization (severe TRD with suicidal ideation) often transition to sublingual maintenance once they're past crisis. The clean handoff works when both providers communicate. The pharmacokinetics differ enough that prior IV experience doesn't always predict sublingual tolerability, so most prescribers start the at-home dose at the standard new-patient level.

What's the response rate difference between clinic and at-home ketamine?

In published real-world data, IV clinic-based protocols see 65-75% response in treatment-resistant depression. Sublingual at-home protocols see 60-70% in comparable populations. The gap is small enough to be within population variance — and the larger variable is whether the patient stays in treatment long enough to see results, which is where at-home's lower cost and convenience often produce the better real-world outcome.

Ready to See Which Setting Fits You?

At Discreet Ketamine, I only take on patients who are genuinely appropriate for at-home treatment, and I refer out the ones who aren't. I review every intake personally before any prescription is issued. For a related patient-perspective piece on the same decision, see why I chose at-home ketamine over clinic visits.

The five-minute eligibility check will give you a quick answer on whether at-home is the right fit, or whether a clinic referral makes more sense for your case.